Filing Flows › Opus Genetics (IRD) › Recalls, complaints & regulation
Opus Genetics (IRD): clinical trials
Opus Genetics (IRD) beyond its filings: 4 active clinical trials.
Opus Genetics' latest quarter
Opus Genetics, Q2 2026: revenue $755K (-74% year over year), net loss $8.1M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Opus Genetics have?
4 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.